175 related articles for article (PubMed ID: 15505366)
1. Interaction of Alzheimer's disease amyloid beta peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain.
Pérez M; Cuadros R; Benítez MJ; Jiménez JS
J Alzheimers Dis; 2004 Oct; 6(5):461-7. PubMed ID: 15505366
[TBL] [Abstract][Full Text] [Related]
2. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
3. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
[TBL] [Abstract][Full Text] [Related]
4. The zinc dyshomeostasis hypothesis of Alzheimer's disease.
Craddock TJ; Tuszynski JA; Chopra D; Casey N; Goldstein LE; Hameroff SR; Tanzi RE
PLoS One; 2012; 7(3):e33552. PubMed ID: 22457776
[TBL] [Abstract][Full Text] [Related]
5. Differential Binding and Conformational Dynamics of Tau Microtubule-Binding Repeats with a Preformed Amyloid-β Fibril Seed.
Song Z; Gatch AJ; Sun Y; Ding F
ACS Chem Neurosci; 2023 Apr; 14(7):1321-1330. PubMed ID: 36975100
[TBL] [Abstract][Full Text] [Related]
6. Interplay of isoform 1N4R tau protein and amyloid-β peptide fragment 25-35 in reducing and non-reducing conditions.
Mohammadi F; Takalloo Z; Rahmani H; Nasiri Khalili MA; Khajeh K; Riazi G; H Sajedi R
J Biochem; 2021 Feb; 169(1):119-134. PubMed ID: 32857841
[TBL] [Abstract][Full Text] [Related]
7. Interaction between Alzheimer's Abeta1-42 peptide and DNA detected by surface plasmon resonance.
Barrantes A; Rejas MT; Benítez MJ; Jiménez JS
J Alzheimers Dis; 2007 Dec; 12(4):345-55. PubMed ID: 18198421
[TBL] [Abstract][Full Text] [Related]
8. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
[TBL] [Abstract][Full Text] [Related]
9. Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease.
Guo JP; Arai T; Miklossy J; McGeer PL
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1953-8. PubMed ID: 16446437
[TBL] [Abstract][Full Text] [Related]
10. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
Tamaoka A
Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
12. Global Conformation of Tau Protein Mapped by Raman Spectroscopy.
Gorantla NV; Khandelwal P; Poddar P; Chinnathambi S
Methods Mol Biol; 2017; 1523():21-31. PubMed ID: 27975242
[TBL] [Abstract][Full Text] [Related]
13. The Neuronal Tau Protein Blocks in Vitro Fibrillation of the Amyloid-β (Aβ) Peptide at the Oligomeric Stage.
Wallin C; Hiruma Y; Wärmländer SKTS; Huvent I; Jarvet J; Abrahams JP; Gräslund A; Lippens G; Luo J
J Am Chem Soc; 2018 Jul; 140(26):8138-8146. PubMed ID: 29708745
[TBL] [Abstract][Full Text] [Related]
14. beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease.
Giaccone G; Pedrotti B; Migheli A; Verga L; Perez J; Racagni G; Smith MA; Perry G; De Gioia L; Selvaggini C; Salmona M; Ghiso J; Frangione B; Islam K; Bugiani O; Tagliavini F
Am J Pathol; 1996 Jan; 148(1):79-87. PubMed ID: 8546229
[TBL] [Abstract][Full Text] [Related]
15. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
[TBL] [Abstract][Full Text] [Related]
16. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
Cottingham MG; Hollinshead MS; Vaux DJ
Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014
[TBL] [Abstract][Full Text] [Related]
17. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
Thal DR; Fändrich M
Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
[No Abstract] [Full Text] [Related]
18. Dependence of the Formation of Tau and Aβ Peptide Mixed Aggregates on the Secondary Structure of the N-Terminal Region of Aβ.
Rojas AV; Maisuradze GG; Scheraga HA
J Phys Chem B; 2018 Jul; 122(28):7049-7056. PubMed ID: 29940109
[TBL] [Abstract][Full Text] [Related]
19. Nonphosphorylated tau slows down Aβ
Beeg M; Battocchio E; De Luigi A; Colombo L; Natale C; Cagnotto A; Corbelli A; Fiordaliso F; Diomede L; Salmona M; Gobbi M
J Biol Chem; 2021; 296():100664. PubMed ID: 33865852
[TBL] [Abstract][Full Text] [Related]
20. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
Zhang ZX; Zhao RP; Wang DS; Li YB
Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
